Matches in Wikidata for { <http://www.wikidata.org/entity/Q91026099> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q91026099 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91026099 description "scientific article published on 25 October 2019" @default.
- Q91026099 description "wetenschappelijk artikel" @default.
- Q91026099 description "наукова стаття, опублікована 25 жовтня 2019" @default.
- Q91026099 name "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 name "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 type Item @default.
- Q91026099 label "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 label "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 prefLabel "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 prefLabel "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 P1433 Q91026099-4634586C-DDDC-481B-AA8D-1D09E54FC3D8 @default.
- Q91026099 P1476 Q91026099-008B213D-5427-4548-AA76-4B1D1DAAAD8C @default.
- Q91026099 P2093 Q91026099-2675D9D4-C089-4349-9092-44EB00F063EA @default.
- Q91026099 P2860 Q91026099-1D6F44CC-6ECA-4F26-AA5E-B73208E5360A @default.
- Q91026099 P2860 Q91026099-25F13DFF-3CF7-47CE-B68A-6D57109E3914 @default.
- Q91026099 P2860 Q91026099-4C6767D1-5805-4D22-B212-EB84CA3338C2 @default.
- Q91026099 P2860 Q91026099-5565D747-2D34-4DB5-84AC-402DB18E96AF @default.
- Q91026099 P2860 Q91026099-59EE5279-74BD-425D-8A80-44FA1C56EF86 @default.
- Q91026099 P2860 Q91026099-BA5EA56C-78CF-4D12-91CD-46B37755A992 @default.
- Q91026099 P2860 Q91026099-D077DBA8-7DA7-44AA-A319-C4D7BF7A0F21 @default.
- Q91026099 P2860 Q91026099-D55A1EE2-9CF2-4BF8-A214-202E958D265C @default.
- Q91026099 P2860 Q91026099-FF79BDC3-295F-463E-8048-6E35586DC44E @default.
- Q91026099 P304 Q91026099-B21BB129-A1CA-4041-B199-0FE690A52DD5 @default.
- Q91026099 P31 Q91026099-4E346208-0E5A-45A1-ACEA-3BC97D55E2A4 @default.
- Q91026099 P356 Q91026099-456E3A69-B834-41E8-A57F-3A65F6562993 @default.
- Q91026099 P433 Q91026099-EA732D2E-8C58-4DAD-8F3B-CD28FDA822A5 @default.
- Q91026099 P478 Q91026099-6C8683DB-EFC8-4798-8FDB-B50F5BCF2D86 @default.
- Q91026099 P577 Q91026099-7744A43A-2F1E-41E7-B47C-BB96D7BF2917 @default.
- Q91026099 P698 Q91026099-3D3D3C43-8E0E-4811-BF01-F308F8CA4210 @default.
- Q91026099 P921 Q91026099-C99CE2F6-2D7C-4312-9AC4-847452299E04 @default.
- Q91026099 P356 S1470-2045(19)30716-8 @default.
- Q91026099 P698 31669156 @default.
- Q91026099 P1433 Q13747613 @default.
- Q91026099 P1476 "Lorlatinib: a new treatment option for ROS1-positive lung cancer" @default.
- Q91026099 P2093 "Michaël Duruisseaux" @default.
- Q91026099 P2860 Q27853138 @default.
- Q91026099 P2860 Q38402702 @default.
- Q91026099 P2860 Q54118729 @default.
- Q91026099 P2860 Q90480786 @default.
- Q91026099 P2860 Q91026096 @default.
- Q91026099 P2860 Q92454532 @default.
- Q91026099 P2860 Q92973254 @default.
- Q91026099 P2860 Q93057343 @default.
- Q91026099 P2860 Q93066246 @default.
- Q91026099 P304 "1622-1623" @default.
- Q91026099 P31 Q13442814 @default.
- Q91026099 P356 "10.1016/S1470-2045(19)30716-8" @default.
- Q91026099 P433 "12" @default.
- Q91026099 P478 "20" @default.
- Q91026099 P577 "2019-10-25T00:00:00Z" @default.
- Q91026099 P698 "31669156" @default.
- Q91026099 P921 Q27285820 @default.